首页> 美国卫生研究院文献>Scientific Reports >Construction of a Corneal Stromal Equivalent with SMILE-Derived Lenticules and Fibrin Glue
【2h】

Construction of a Corneal Stromal Equivalent with SMILE-Derived Lenticules and Fibrin Glue

机译:具有SMILE衍生的小透镜和纤维蛋白胶的角膜基质间质的构建

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The scarcity of corneal tissue to treat deep corneal defects and corneal perforations remains a challenge. Currently, small incision lenticule extraction (SMILE)-derived lenticules appear to be a promising alternative for the treatment of these conditions. However, the thickness and toughness of a single piece of lenticule are limited. To overcome these limitations, we constructed a corneal stromal equivalent with SMILE-derived lenticules and fibrin glue. In vitro cell culture revealed that the corneal stromal equivalent could provide a suitable scaffold for the survival and proliferation of corneal epithelial cells, which formed a continuous pluristratified epithelium with the expression of characteristic markers. Finally, anterior lamellar keratoplasty in rabbits demonstrated that the corneal stromal equivalent with decellularized lenticules and fibrin glue could repair the anterior region of the stroma, leading to re-epithelialization and recovery of both transparency and ultrastructural organization. Corneal neovascularization, graft degradation, and corneal rejection were not observed within 3 months. Taken together, the corneal stromal equivalent with SMILE-derived lenticules and fibrin glue appears to be a safe and effective alternative for the repair of damage to the anterior cornea, which may provide new avenues in the treatment of deep corneal defects or corneal perforations.
机译:缺乏治疗深层角膜缺损和角膜穿孔的角膜组织仍然是一个挑战。目前,小切口小孔镜提取(SMILE)衍生的小孔似乎是治疗这些疾病的有前途的替代方法。但是,单片微透镜的厚度和韧性受到限制。为了克服这些限制,我们用SMILE衍生的微透镜和纤维蛋白胶构建了角膜基质等效物。体外细胞培养表明,角膜基质等效物可以为角膜上皮细胞的存活和增殖提供合适的支架,从而形成具有特征性标志物表达的连续的多层次上皮细胞。最后,兔前板层角膜移植术表明,角膜基质等效物与去细胞的小孔和纤维蛋白胶可以修复基质的前部区域,从而导致上皮重新形成,并恢复透明性和超微结构。在3个月内未观察到角膜新生血管,移植物降解和角膜排斥。综上所述,角膜基质等效物与SMILE衍生的小透镜和纤维蛋白胶看来是修复前角膜损伤的安全有效的替代方法,这可以为深层角膜缺损或角膜穿孔的治疗提供新途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号